标题
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
作者
关键词
Cellular transformation, Ras, RBD, Tet-off system, MSOR: <em class=EmphasisTypeItalic >m</em> ultivalent <em class=EmphasisTypeItalic >s</em> cavengers of <em class=EmphasisTypeItalic >o</em> ncogenic <em class=EmphasisTypeItalic >R</em> as
出版物
Cell Communication and Signaling
Volume 12, Issue 1, Pages 1
出版商
Springer Nature
发表日期
2014-01-03
DOI
10.1186/1478-811x-12-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells
- (2013) S. Kothe et al. JOURNAL OF CELL SCIENCE
- Effects of Raf Dimerization and Its Inhibition on Normal and Disease-Associated Raf Signaling
- (2013) Alyson K. Freeman et al. MOLECULAR CELL
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
- (2013) Cosimo Commisso et al. NATURE
- Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
- (2013) Gunther Zimmermann et al. NATURE
- Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization
- (2013) Hugo Lavoie et al. Nature Chemical Biology
- Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function
- (2013) H. J. Hocker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction
- (2013) F. Shima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
- (2013) C. Posch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
- (2012) Qi Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting oncogenic Ras signaling in hematologic malignancies
- (2012) A. F. Ward et al. BLOOD
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- RAS/RAF/MEK Inhibitors in Oncology
- (2012) M. Broggini CURRENT MEDICINAL CHEMISTRY
- Live-cell imaging of endogenous Ras-GTP shows predominant Ras activation at the plasma membrane and in the nucleus in Saccharomyces cerevisiae
- (2012) Serena Broggi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
- (2011) L S Steelman et al. LEUKEMIA
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Raf kinases in cancer–roles and therapeutic opportunities
- (2011) G Maurer et al. ONCOGENE
- Ras trafficking, localization and compartmentalized signalling
- (2011) Ian A. Prior et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- TCR-Induced Activation of Ras Proceeds at the Plasma Membrane and Requires Palmitoylation of N-Ras
- (2010) I. Rubio et al. JOURNAL OF IMMUNOLOGY
- Nox4-Derived H2O2 Mediates Endoplasmic Reticulum Signaling through Local Ras Activation
- (2010) R.-F. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Interfering with RAS–effector protein interactions prevent RAS-dependent tumour initiation and causes stop–start control of cancer growth
- (2010) T Tanaka et al. ONCOGENE
- Partner exchange: protein–protein interactions in the Raf pathway
- (2010) Reiner Wimmer et al. TRENDS IN BIOCHEMICAL SCIENCES
- Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D
- (2009) Alessandro Palmioli et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
- (2009) William E Tidyman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients
- (2007) Kenneth D. Swanson et al. GENES CHROMOSOMES & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started